v3.25.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Assets [Abstract]    
Cash and cash equivalents $ 531,043 $ 377,099
Cash collateral posted to counterparties 399,344 244,440
Mortgage-backed securities (including pledged assets of $14,593,470 and $6,893,629, respectively), at fair value 16,306,988 7,512,087
Due from counterparties 17,425 10,445
Derivative assets 10,498 133
Accrued interest receivable 67,940 32,841
Other assets 8,940 7,534
Total assets 17,342,178 8,184,579
Liabilities:    
Repurchase agreements 13,904,231 6,563,120
Due to counterparties 811,656 341,924
Derivative liabilities 4,830 22,814
Cash collateral posted by counterparties 8,373 0
Accrued interest payable 95,196 44,672
Dividends payable 37,171 16,501
Other liabilities 18,577 10,612
 Total liabilities 14,880,034 6,999,643
Stockholders' Equity Attributable to Parent [Abstract]    
Preferred stock, par value $0.01 per share; 50,000,000 shares authorized; 4,460,000 and 4,460,000 shares issued and outstanding, respectively ($111,500 and $111,500 aggregate liquidation preference, respectively) 107,843 107,843
Common stock, par value $0.01 per share, 360,000,000 shares authorized; 174,814,912 and 84,491,800 shares issued and outstanding, respectively 1,748 845
Additional paid-in capital 2,921,551 1,742,471
Accumulated other comprehensive loss (127,061) (172,489)
Accumulated deficit (441,937) (493,734)
 Total shareholders’ equity 2,462,144 1,184,936
Total liabilities and shareholders’ equity $ 17,342,178 $ 8,184,579

Source

10-K PDF XBRL Zip